Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control Study.

Frontiers in bioscience (Landmark edition) - 24 Sept 2023

Wang Yunchao, Li Zhi, Zhang Xiaoyi, Lin Ao, Chen Cuiyi, Zeng Xiaobin, Pan Yujie, Mao Chun, Xie Chenli, Huang Dongsheng, Deng Yibin, Zhang Xuhui, Lu Jiachun, Wang Xinhua

Abstract excerpt

BACKGROUND: The occurrence and development of chronic obstructive pulmonary disease (COPD) are regulated by environmental and genetic factors. In hypoxia, Erythropoietin (EPO) satisfies the body's need for oxygen by promoting the production of red blood cells. Hypoxia was proven to be a common physiological condition in COPD progression and associated with many complications. Some studies have found that EPO is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Erythropoietin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hypoxia

Share to Polymorphism, Single Nucleotide

Share to Protective Factors

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 37796693
DOI: 10.31083/j.fbl2809215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control Study.PMID 37796693Read ↗

EPO rs1617640 A>C is a protective factor for chronic obstructive pulmonary disease: a case control studySemantic proximity Read ↗

EPAS1 and VEGFA Polymorphisms Modulate COPD Susceptibility in a High-Altitude Population: A Case-Control Study.Semantic proximity Read ↗

GSTP1 rs4147581 C>G and NLRP3 rs3806265 T>C as Risk Factors for Chronic Obstructive Pulmonary Disease: A Case-Control Study.Semantic proximity Read ↗

HIF1A gene rs10873142 polymorphism is associated with risk of chronic obstructive pulmonary disease in a Chinese Han population: a case-control study.Semantic proximity Read ↗

Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control study.Semantic proximity Read ↗

Associations between HIF-1α polymorphisms C1772T and G1790A and susceptibility to chronic obstructive pulmonary disease.Semantic proximity Read ↗

Association Between the Oxidative Stress Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk: A Meta-AnalysisSemantic proximity Read ↗

The effects of CXCL10 polymorphisms on COPD susceptibility.Semantic proximity Read ↗

Polymorphisms in VEGF-A are associated with COPD risk in the Chinese population from Hainan province.Semantic proximity Read ↗

Association between the oxidative stress gene polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis.Semantic proximity Read ↗

A Case-Control Study of the Associations between EGLN1 Gene Polymorphisms and COPD.Semantic proximity Read ↗

Effect of PRDX6 gene polymorphism on susceptibility to chronic obstructive pulmonary disease in the Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.